Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
|
|
28.
|
|
|
29.
|
TPF plus cetuximab induction chemotherapy followed by biochemoradiation with weekly cetuximab plus weekly cisplatin or carboplatin: a randomized phase II EORTC trial. [electronic resource] by
- Specenier, P M
- Remenar, E
- Buter, J
- Schrijvers, D L
- Bergamini, C
- Licitra, L F
- Awada, A
- Clement, P M
- Fortpied, C
- Menis, J
- Vermorken, J B
Producer: 20180523
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 28
Availability: No items available.
|
|
30.
|
Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study. [electronic resource] by
- Licitra, L
- Mesia, R
- Rivera, F
- Remenár, É
- Hitt, R
- Erfán, J
- Rottey, S
- Kawecki, A
- Zabolotnyy, D
- Benasso, M
- Störkel, S
- Senger, S
- Stroh, C
- Vermorken, J B
Producer: 20110810
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 22
Availability: No items available.
|
|
31.
|
The effect of leukocyte interleukin injection (Multikine) treatment on the peritumoral and intratumoral subpopulation of mononuclear cells and on tumor epithelia: a possible new approach to augmenting sensitivity to radiation therapy and chemotherapy in oral cancer--a multicenter phase I/II clinical Trial. [electronic resource] by
- Tímár, József
- Forster-Horváth, C
- Lukits, J
- Döme, B
- Ladányi, A
- Remenár, E
- Kásler, M
- Bencsik, M
- Répássy, G
- Szabó, G
- Velich, N
- Suba, Z
- Elõ, J
- Balatoni, Z
- Bajtai, A
- Chretien, P
- Talor, Eyal
Producer: 20040108
In:
The Laryngoscope vol. 113
Availability: No items available.
|
|
32.
|
Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part). [electronic resource] by
- Vermorken, J B
- Peyrade, F
- Krauss, J
- Mesía, R
- Remenar, E
- Gauler, T C
- Keilholz, U
- Delord, J P
- Schafhausen, P
- Erfán, J
- Brümmendorf, T H
- Iglesias, L
- Bethe, U
- Hicking, C
- Clement, P M
Producer: 20141118
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 25
Availability: No items available.
|
|
33.
|
Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323). [electronic resource] by
- van Herpen, C M L
- Mauer, M E
- Mesia, R
- Degardin, M
- Jelic, S
- Coens, C
- Betka, J
- Bernier, J
- Remenar, E
- Stewart, J S
- Preiss, J H
- van den Weyngaert, D
- Bottomley, A
- Vermorken, J B
Producer: 20101104
In:
British journal of cancer vol. 103
Availability: No items available.
|
|
34.
|
Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 study. [electronic resource] by
- Psyrri, A
- Fortpied, C
- Koutsodontis, G
- Avgeris, M
- Kroupis, C
- Goutas, N
- Menis, J
- Herman, L
- Giurgea, L
- Remenár, É
- Degardin, M
- Pateras, I S
- Langendijk, J A
- van Herpen, C M L
- Awada, A
- Germà-Lluch, J R
- Kienzer, H R
- Licitra, L
- Vermorken, J B
Producer: 20180523
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 28
Availability: No items available.
|